| Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors AT Sourav Pal, Vinay Kumar, Biswajit Kundu, Debomita Bhattacharya, Nagothy ... Computational and Structural Biotechnology Journal 17, 291-310, 2019 | 130 | 2019 |
| Discovery and mechanistic study of tailor-made quinoline derivatives as topoisomerase 1 poison with potent anticancer activity B Kundu, SK Das, S Paul Chowdhuri, S Pal, D Sarkar, A Ghosh, ... Journal of medicinal chemistry 62 (7), 3428-3446, 2019 | 54 | 2019 |
| Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9 B Kundu, D Raychaudhuri, A Mukherjee, BP Sinha, D Sarkar, ... Journal of Medicinal Chemistry, 2021 | 16 | 2021 |
| Activity-guided development of potent and selective toll-like receptor 9 antagonists B Paul, O Rahaman, S Roy, S Pal, S Satish, A Mukherjee, AR Ghosh, ... European journal of medicinal chemistry 159, 187-205, 2018 | 16 | 2018 |
| Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism S Roy, A Mukherjee, B Paul, O Rahaman, S Roy, G Maithri, B Ramya, ... European journal of medicinal chemistry 134, 334-347, 2017 | 14 | 2017 |
| Emergence of multiple variants of SARS-CoV-2 with signature structural changes D Bhowmik, S Pal, A Lahiri, A Talukdar, S Paul bioRxiv, 2020 | 10 | 2020 |
| Synthesis and Characterization of New Potent TLR7 Antagonists Based on Analysis of the Binding Mode using Biomolecular Simulations S Pal, B Paul, P Bandopadhyay, N Preethy, D Sarkar, O Rahaman, ... European Journal of Medicinal Chemistry, 112978, 2020 | 9 | 2020 |
| Development of a metabolically stable topoisomerase I poison as anticancer agent B Kundu, D Sarkar, SP Chowdhuri, S Pal, SK Das, BB Das, A Talukdar European Journal of Medicinal Chemistry, 112551, 2020 | 9 | 2020 |
| Compilation of Potential Protein Targets for SARS-CoV-2: Preparation of Homology Model and Active Site Determination for Future Rational Antiviral Design S Pal, A Talukdar ChemRxiv, 2020 | 9 | 2020 |
| Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant … N Das, P Bandopadhyay, S Roy, BP Sinha, UG Dastidar, O Rahaman, ... Journal of Medicinal Chemistry, 2022 | 8 | 2022 |
| Integration of Ligand-Based and Structure-Based Methods for the Design of Small-Molecule TLR7 Antagonists S Pal, U Ghosh Dastidar, T Ghosh, D Ganguly, A Talukdar Molecules 27 (13), 4026, 2022 | 4 | 2022 |
| Computational Approaches Toward Development of Topoisomerase I Inhibitor: A Clinically Validated Target A Talukdar, S Pal Molecular Docking for Computer-Aided Drug Design, 441-462, 2021 | | 2021 |
Shounak Roy, Ph.DIndian Institute of Technology Mandi | Fulbright-Nehru Doctoral FellowVerified email at students.iitmandi.ac.in
